Dabuzalgron
Dabuzalgron is an orally active selective alpha-1A adrenergic receptor agonist used to treat urinary incontinence. Dabuzaron prevents cardiotoxicity caused by doxorubicin by maintaining mitochondrial function.Dabuzaron treatment increased ERK phosphorylation in a dose-dependent manner with an EC50 of 4.8 μM.
Product Specifications
CAS Number
219311-44-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
317.79
Molecular Formula
C12H16ClN3O3S
Notes
Research use only, not for human use.
Receptor
Α1A-adrenergic receptor
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15240120 1 Vial
Lentiviral mouse Rgs12 shRNA (UAS) - Lentiviral mouse Rgs12 shRNA (UAS, RFP) (100)
Ask
View Details 
372457-01 20 µg
BLOT5, Recombinant, Blomia tropicalis, aa1-134, His-SUMO-Tag (Mite Allergen Blo t 5)
Ask
View Details 372457-02 100 µg
BLOT5, Recombinant, Blomia tropicalis, aa1-134, His-SUMO-Tag (Mite Allergen Blo t 5)
Ask
View Details EKN47065 96 Tests
Human Microtubule Associated Protein RP/EB Family, Member 1 (MAPRE1) ELISA Kit
Ask
View Details